ID H0481

Creates Idaho's "Right to Try Act" allowing terminally ill patients to request investigational drugs, biological products, or devices that have completed phase 1 clinical trials but lack FDA approval, with physician recommendation and written informed consent.

Permits manufacturers to provide investigational treatments to eligible patients without compensation or to charge for manufacturing costs, but does not require manufacturers to provide them.

Prohibits health plans, insurers, government agencies, and hospitals from being required to cover costs associated with investigational treatments or related services.

Protects physicians and other healthcare providers from professional license revocation, suspension, or disciplinary action solely based on recommending access to investigational treatments allowed under this act.

Shields manufacturers and providers from private lawsuits for harm resulting from investigational treatments if they exercise reasonable care and comply in good faith with the chapter's terms; protects patient heirs from liability for treatment-related debt.